Search results
Results From The WOW.Com Content Network
Estimates of the prevalence of AFib in the United States range from about 3 million to 6 million. That number is estimated to rise to 12.1 million in 2030. Worldwide, the estimated...
Based on data from the FHS (Framingham Heart Study), the prevalence of AF increased 3-fold over the last 50 years. 1 The Global Burden of Disease project estimated a worldwide prevalence of AF around 46.3 million individuals in 2016. 6 The lifetime risk of AF was estimated about 1 in 4 in white men and women older than 40 years in 2004 7; a deca...
Facts about AFib. It is estimated that 12.1 million people in the US will have AFib in S 1 2. In 2021, AFib was mentioned on 232,030 death certificates and was the underlying cause of death in 28,037 of those deaths. 3. People of European descent are more likely to have AFib than Black people.
Atrial fibrillation is the leading cardiac cause of stroke. Risk factors for atrial fibrillation include advanced age, high blood pressure, underlying heart and lung disease, congenital heart disease, and increased alcohol consumption.
AFib itself usually isn't life-threatening. But it's a serious medical condition that needs proper treatment to prevent stroke. Treatment for atrial fibrillation may include medicines, therapy to shock the heart back to a regular rhythm and procedures to block faulty heart signals.
Women with atrial fibrillation exhibited a greater excess mortality risk than men (standardized mortality ratio 3.81, 95% confidence interval 3.65–3.98 in women; standardized mortality ratio 3.35, 95% confidence interval 3.21–3.48 in men).
In 2010, the global number of individuals suffering from AF was computed to be approximately 33.5 million, with increasing incidence and prevalence trends since the nineties. 3 These estimations are expected to further increase in future and are projected to reach 12.1 million people in the USA by 2050 and 17.9 million people in Europe by 2060. ...
Atrial fibrillation (AF) is highly prevalent with a lifetime risk of about 1 in 3–5 individuals after the age of 45 years. Between 2010 and 2019, the global prevalence of AF has risen markedly from 33.5 million to 59 million individuals living with AF.
It has been estimated that 6-12 million people worldwide will suffer this condition in the US by 2050 and 17.9 million people in Europe by 2060. Atrial fibrillation is a major risk factor for ischemic stroke and provokes important economic burden along with significant morbidity and mortality.
Reductions in the rates of stroke and coronary heart disease during the past decades have not been accompanied by reductions in the rates of atrial fibrillation, highlighting the need to develop preventive strategies for this common arrhythmia.